Brett Lauring

3.1k total citations
40 papers, 2.3k citations indexed

About

Brett Lauring is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Brett Lauring has authored 40 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 20 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Cell Biology. Recurrent topics in Brett Lauring's work include Diabetes Treatment and Management (19 papers), Metabolism, Diabetes, and Cancer (19 papers) and Cellular transport and secretion (6 papers). Brett Lauring is often cited by papers focused on Diabetes Treatment and Management (19 papers), Metabolism, Diabetes, and Cancer (19 papers) and Cellular transport and secretion (6 papers). Brett Lauring collaborates with scholars based in United States, United Kingdom and France. Brett Lauring's co-authors include Steven G. Terra, Susan Huyck, Gregory T. Golm, Gert Kreibich, James P. Mancuso, Jeremy Johnson, Samuel S. Engel, Amanda Darekar, Martin Wiedmann and Juan P. Frías and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Brett Lauring

40 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brett Lauring United States 23 1.4k 1.2k 440 406 330 40 2.3k
Rachael Easton United States 16 1.1k 0.8× 262 0.2× 345 0.8× 115 0.3× 189 0.6× 24 1.8k
Antonio E. Rusiñol United States 22 1.6k 1.2× 145 0.1× 407 0.9× 434 1.1× 109 0.3× 29 2.3k
Bernard Rothhut France 27 1.2k 0.9× 136 0.1× 119 0.3× 164 0.4× 96 0.3× 53 1.8k
Takeshi Endo Japan 15 711 0.5× 285 0.2× 126 0.3× 106 0.3× 178 0.5× 31 1.3k
Guy E. Groblewski United States 25 1.0k 0.7× 100 0.1× 537 1.2× 508 1.3× 194 0.6× 60 1.9k
Bhavapriya Vaitheesvaran United States 17 1.2k 0.9× 197 0.2× 257 0.6× 121 0.3× 255 0.8× 20 2.3k
Anne Guiochon‐Mantel France 21 753 0.5× 286 0.2× 120 0.3× 87 0.2× 83 0.3× 39 1.4k
Gisèle Cherqui France 21 1.2k 0.9× 232 0.2× 248 0.6× 168 0.4× 77 0.2× 66 1.8k
Celia M. Pombo Spain 20 980 0.7× 160 0.1× 87 0.2× 345 0.8× 80 0.2× 27 1.6k
Carol L. Sable United States 12 1.3k 0.9× 113 0.1× 130 0.3× 161 0.4× 162 0.5× 14 1.7k

Countries citing papers authored by Brett Lauring

Since Specialization
Citations

This map shows the geographic impact of Brett Lauring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Lauring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Lauring more than expected).

Fields of papers citing papers by Brett Lauring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Lauring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Lauring. The network helps show where Brett Lauring may publish in the future.

Co-authorship network of co-authors of Brett Lauring

This figure shows the co-authorship network connecting the top 25 collaborators of Brett Lauring. A scholar is included among the top collaborators of Brett Lauring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett Lauring. Brett Lauring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cannon, Christopher P., Darren K. McGuire, Richard E. Pratley, et al.. (2018). DESIGN AND BASELINE CHARACTERISTICS OF THE EVALUATION OF ERTUGLIFOZIN EFFICACY AND SAFETY CARDIOVASCULAR OUTCOMES TRIAL (VERTIS-CV). Journal of the American College of Cardiology. 71(11). A1825–A1825. 55 indexed citations
2.
Miller, Sam S., Hao Zhou, Susan Huyck, et al.. (2018). Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study. Diabetes Therapy. 9(1). 253–268. 70 indexed citations
3.
Liu, Jie, Lisa Tarasenko, Annpey Pong, et al.. (2018). Efficacy and Safety of Ertugliflozin across Racial Groups in Patients with Type 2 Diabetes Mellitus (T2DM). Diabetes. 67(Supplement_1). 1 indexed citations
4.
Calle, Roberto A., Jie Liu, Susan Huyck, et al.. (2018). A Pooled Analysis of the Efficacy and Safety of Ertugliflozin as Add-On Therapy to Metformin. Diabetes. 67(Supplement_1). 1 indexed citations
5.
Cannon, Christopher P., Darren K. McGuire, Richard E. Pratley, et al.. (2018). Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV). American Heart Journal. 206. 11–23. 160 indexed citations
6.
Hollander, Priscilla, Jie Liu, Julie Hill, et al.. (2017). Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study. Diabetes Therapy. 9(1). 193–207. 88 indexed citations
7.
Grunberger, George, Jeremy Johnson, Susan Huyck, et al.. (2017). Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study. Diabetes Therapy. 9(1). 49–66. 111 indexed citations
8.
Terra, Steven G., Kristen Focht, Melanie J. Davies, et al.. (2017). Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone. Diabetes Obesity and Metabolism. 19(5). 721–728. 117 indexed citations
9.
Lauring, Brett, Xiujiang Li, Yang Liu, et al.. (2014). Influence of renal and hepatic impairment on the pharmacokinetics of anacetrapib. The Journal of Clinical Pharmacology. 54(11). 1247–1255. 8 indexed citations
10.
Lauring, Brett, Victor Dishy, Pieter‐Jan de Kam, et al.. (2014). Effects of Extended-Release Niacin and Extended-Release Niacin/Laropiprant on the Pharmacokinetics of Simvastatin in Healthy Subjects. American Journal of Therapeutics. 22(5). 367–376. 1 indexed citations
11.
Taylor, Jennifer, et al.. (2012). Crystal structure of the human spastin AAA domain. Journal of Structural Biology. 179(2). 133–137. 19 indexed citations
12.
Lauring, Brett, Victor Dishy, Wen‐Lin Luo, et al.. (2009). Laropiprant in Combination With Extended‐Release Niacin Does Not Alter Urine 11‐Dehydrothromboxane B2, a Marker of In Vivo Platelet Function, in Healthy, Hypercholesterolemic, and Diabetic Subjects. The Journal of Clinical Pharmacology. 49(12). 1426–1435. 12 indexed citations
13.
Lauring, Brett, et al.. (2007). AAA+ ATPases: Achieving Diversity of Function with Conserved Machinery. Traffic. 8(12). 1657–1667. 176 indexed citations
14.
Keller, Christian E. & Brett Lauring. (2005). Possible regulation of microtubules through destabilization of tubulin. Trends in Cell Biology. 15(11). 571–573. 12 indexed citations
15.
Black, Virginia H., Archana Sanjay, Klaus van Leyen, Brett Lauring, & Gert Kreibich. (2005). Cholesterol and Steroid Synthesizing Smooth Endoplasmic Reticulum of Adrenocortical Cells Contains High Levels of Proteins Associated with the Translocation Channel. Endocrinology. 146(10). 4234–4249. 16 indexed citations
16.
Martinez, Jessica A., et al.. (2003). Parkinson's Disease-associated α-Synuclein Is a Calmodulin Substrate. Journal of Biological Chemistry. 278(19). 17379–17387. 77 indexed citations
17.
18.
Möller, Ines, Birgitta Beatrix, Gert Kreibich, et al.. (1998). Unregulated exposure of the ribosomal M‐site caused by NAC depletion results in delivery of non‐secretory polypeptides to the Sec61 complex. FEBS Letters. 441(1). 1–5. 31 indexed citations
19.
Lauring, Brett, Hideaki Sakai, Teresa A. Davis, et al.. (1995). Nascent-polypeptide-associated Complex: A Bridge between Ribosome and Cytosol. Cold Spring Harbor Symposia on Quantitative Biology. 60(0). 47–56. 10 indexed citations
20.
Lauring, Brett, Gert Kreibich, & Manfred Weidmann. (1995). The intrinsic ability of ribosomes to bind to endoplasmic reticulum membranes is regulated by signal recognition particle and nascent-polypeptide-associated complex.. Proceedings of the National Academy of Sciences. 92(21). 9435–9439. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachael Easton Breakdown of academic impact, for papers by Antonio E. Rusiñol Breakdown of academic impact, for papers by Bernard Rothhut Breakdown of academic impact, for papers by Takeshi Endo Breakdown of academic impact, for papers by Guy E. Groblewski Breakdown of academic impact, for papers by Bhavapriya Vaitheesvaran Breakdown of academic impact, for papers by Anne Guiochon‐Mantel Breakdown of academic impact, for papers by Gisèle Cherqui Breakdown of academic impact, for papers by Celia M. Pombo Breakdown of academic impact, for papers by Carol L. Sable
Rankless by CCL
2026